Acidity Test Kit

ExProbeTM SARS-CoV-2 qPCR Testing Kit EU CE Marked, US FDA EUA Approved, Taiwan FDA EUA Approved Intended Use: To detect RdRP/N/E RNA SARS-CoV-2 (COVID-19) in NP/O swabs and sputum.  Product Format: 96 tests/kit Kit Contents: PCR Mix, Enzyme Mix, Pos. Control, Neg. Control and Instruction For Use. Storage / Stability: -20C + 5C / 6 months, repeat freeze thaw x 4. Testing kit is compatible for ABI7500,Roche 4800, TBG Q6000 qPCR Systems Reproducibility / Precision 100% Concordant across 3 lots with CV + 5% Limits of Detection (LOD) 50 copies/reaction Performance Comparison* Positive Samples 5 / 5 Negative Samples 199/200

GOLD STANDARD for diagnosis novel coronavirus. This kit is based on one-step RT-PCR technique. Used for the in vitro qualitative detection of novel coronavirus (2019-nCoV) ORF1ab and N gene in the throat swabs, sputum specimens of suspected pneumonia patients infected by novel coronavirus, suspected clustering cases and others needing diagnosis or differential diagnosis for novel coronavirus. No cross-reaction, sensitivity is 500 copies/ml. CFDA/CE. Applicable Instruments include ABI 7500 & LightCycler480.

[Intended Usage] This kit is used for the in vitro qualitative detection of suspected cases of pneumonia caused by New Coronavirus infection, patients with suspected clusters, other patients who need to be diagnosed or differentially diagnosed with the New Coronavirus infection, and nasopharyngeal swabs, oropharyngeal swabs, and bronchoalveolar lavage fluid samples of patients with mutation beads for the New Coronavirus ORF1ab and N gene, S gene N501Y mutation and S gene E484K mutation sites. [Storage Conditions & Validity] 1. The kit should be stored frozen at -20 and protected from light; the expiration date is 6 months; the production date and expiration date are shown in the outer packaging box. 2. Avoid repeated freezing and thawing of the kit and the number of freezing and thawing shall not exceed 7 times. 3. After opening, the bottles should be stored at -20 and protected from light. The number of bottles opening times should not exceed 7 times, which will not affect the use within the validity period. [Applicable Instruments] 1. This kit has been validated on ABI7500 quantitative fluorescence PCR instrument. 2. For other models not listed, relevant experiments have not been performed or completed for this kit. If users need to use this type of instrument platform to carry out the detection of this reagent, please contact our Technical Department at for relevant support. NB: The other devices can include quantitative fluorescence PCR platforms with FAM, VIC, ROX and Cy5 channels. [Sample Requirements] 1. Nasopharyngeal swabs, oropharyngeal swabs and other methods are used to obtain samples, and it is recommended to use commercial virus sampling kits for sample collection devices. [Test Results Interpretation] 1. Negative and positive controls should be tested in each experiment and the test result can be determined only when the controls meet the quality control requirements. 2. When FAM, VIC and ROX channels are positive, Cy5 channel result may be negative due to the system competition. 3. When the internal standard result is negative, if the FAM, VIC and ROX signals of the test sample are also negative, the test result of the sample is invalid, and the cause should be found and eliminated, and the experiment repeated for this sample. [Product Performance Index] 1. Precision: The coefficient of variation Intra-batch / Inter-batch, Intra-day / Inter-day among different operators shall not be higher than 5.0%. 2. Coincidence rate of negative positive controls: The coincidence rate of positive controls and negative controls is 100%. 3. Minimum detection limit: The minimum detection limit of this kit is 500 copies/mL. [CE Mark Registration No.]: RPS/499/2021. [EC REP.]: CMC MEDICAL DEVICES & DRUGS S.L. C/ Horacio Lengo n18, C.P 29006, Milaga, Spain.